FindTrial
Sign In

The clinical experiment research of silicosis fibrosis treatment of high incidence of occupational disease in Xinjiang

Application of protein Microarray combined with SELDI - TOF - MS testing in the clinicial trial of Xinjiang Uygur medicine VAWI treatment of silicosis fibrosis patients serum protein expression differences in research

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007268
Enrollment
Unknown
Registered
2015-10-24
Start date
2014-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

silicosis

Interventions

VAWI group:VAWI
basis treatment group:conventional therapy

Sponsors

Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with silicosis in accordance with the basic standard of pneumoconiosis diagnosis, selection of male, aged 70-80 years old patients with silicosis one period for selected cases.

Exclusion criteria

Exclusion criteria: In one phase of the patients with coronary heart disease, hypertension, rheumatism, diabetes, liver and kidney function abnormal persons were removed.

Design outcomes

Primary

MeasureTime frame
the different protein in serum;—

Countries

China

Contacts

Public ContactGuitao Liu
diandianabcd@163.com+86 18290881168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026